Progress on health inequalities is now at risk, argue Michael Marmot and colleagues , the chairs of a new Global Council on Inequality, AIDS, and Pandemics
The climate emergency and the global rise in inequalities are putting us all at risk. Both will damage health. The global community, with successive climate change conferences (COPs), is taking faltering steps to tackle the climate emergency but is doing little about the inequality crisis. In some countries, political and economic forces are increasing social and economic inequalities, with potentially dire consequences for health inequalities and for people’s vulnerability to pandemics. Unfair distribution of power, money, and resources are driving inequalities in health.1
We’ve been through a good period. Global progress in improving health has been impressive throughout the 20th and early 21st centuries, and health inequalities between countries have diminished. Within countries, too, absolute inequalities in health have le
The Latin America Insulin Delivery Devices Market size is estimated at USD 707.91 million in 2023, and is expected to reach USD 800.94 million by 2028,.
Meet the Most (In)Famous Hacking Groups Active Today makeuseof.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from makeuseof.com Daily Mail and Mail on Sunday newspapers.
The Latin America Oral Anti-Diabetic Drug Market size is expected to grow from USD 3.14 billion in 2023 to USD 3.73 billion by 2028, at a CAGR of 3.50%.
Latin American countries not only developed their own covid vaccine prototypes but also rolled them out. Martín De Ambrosio reports on a region taking its first steps towards vaccine security
When the pandemic shook the world in 2020, Argentina, like many countries, went into full lockdown. Juliana Cassataro, a researcher at the National University of General San Martín, wondered what her team could do to help. The answer was obvious for a researcher specialising in oral vaccines: make one.
“From the beginning we planned to make it as a booster we realised that we couldn’t compete with developers with millions and millions of dollars and the support of bigger nation states,” says Cassataro. Her team received a small grant of $100 000 from the Argentine ministry of science in May 2020 to design a prototype based on Cassataro’s specialism: recombinant protein vaccines.
Confidence was not high. Colleagues and politicians told them to give up it was not feasible to produce a